transitioning from tirzepatide to retatrutide Switching between and for weight loss, diabetes, and inflammation. Even micro-dosing helps with inflammation and feeling better. @terriagcaoili #tirzepatide #retatrutide Retatrutide vs Tirzepatide – Complete

Initially approved for managing Type 2 diabetes, semaglutide has also been shown to promote weight loss in certain doses, making it a popular choice for individuals seeking metabolic health benefits

Both experiences are common, and expected

This powerful antioxidant has recently become a popular beauty treatment for skin lightening and treating severe skin diseases like atopic dermatitis, psoriasis, and eczema

Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) or 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea

As medication costs continue to rise and new therapeutic options emerge, effective approaches for benefit management such as this will become increasingly valuable to all healthcare stakeholders

The FDA recommends limiting caffeine intake to 400 mg daily for most adults, though patients on GLP-1 medications often feel satisfied with 200 mg or lessroughly one 12-ounce cup of coffee